Literature DB >> 20198643

Tyrosine hydroxylase deficiency in three Greek patients with a common ancestral mutation.

Roser Pons1, Mercedes Serrano, Aida Ormazabal, Claudio Toma, Angels Garcia-Cazorla, Estela Area, Marta Ribasés, Emmanuel Kanavakis, Kaliopi Drakaki, Aristotelis Giannakopoulos, Irene Orfanou, Sotiris Youroukos, Bru Cormand, Rafael Artuch.   

Abstract

We present the clinical, biochemical, and molecular findings of three Greek patients with tyrosine hydroxylase (TH) deficiency. All patients presented with a severe clinical phenotype characterized by prominent motor delay, infantile parkinsonism, oculogyric crises, and signs of autonomic dysfunction. Cerebrospinal fluid analysis disclosed reduced dopamine metabolites and normal pterins. Response to levodopa was favorable though not dramatic. All patients were homozygous for a previously reported mutation (p.L236P). SNP haplotype analysis was consistent with a common ancestral mutation, thus indicating a founder effect in Greek patients with TH deficiency. (c) 2010 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20198643     DOI: 10.1002/mds.23002

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  4 in total

1.  Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency.

Authors:  Maria Stamelou; Niccolo E Mencacci; Carla Cordivari; Amit Batla; Nick W Wood; Henry Houlden; John Hardy; Kailash P Bhatia
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

Review 2.  Nonmotor Symptoms in Dopa-Responsive Dystonia.

Authors:  Elena Antelmi; Maria Stamelou; Rocco Liguori; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2015-07-22

Review 3.  Spotlight on Oculogyric Crisis: A Review.

Authors:  Pankaj Mahal; Navratan Suthar; Naresh Nebhinani
Journal:  Indian J Psychol Med       Date:  2020-09-03

Review 4.  Dopa-responsive dystonia caused by tyrosine hydroxylase deficiency: Three cases report and literature review.

Authors:  Han-Yu Dong; Jun-Yan Feng; Xiao-Jing Yue; Ling Shan; Fei-Yong Jia
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.